All changes for the tissue Anatomical System (4331)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA1882
replication factor C (activator 1) 5
Molecular
skeletal muscle
Mouse
Rfc5
13.0% Decrease Gene Expression Level
DAA204
replication factor C (activator 1) 5, 36.5kDa
Molecular
brain
Human
RFC5
7.0% Decrease Gene Expression Level
DAA811
Respiratory drive decreases
Physiological
respiratory system
Human
—
—
DAA810
Respiratory muscle strength declines
Physiological
respiratory system, muscle
Human
—
—
DAA810
Respiratory muscle strength declines
Physiological
respiratory system, muscle
Human
—
—
DAA812
Responses to hypoxemia and hypercapnia are decreased
Physiological
respiratory system
Human
—
—
DAA897
Response to antidiuretic hormone decreased
Physiological
renal tubule
Human
—
—
DAA708
Response to beta-adrenergic stimulation decreased
Physiological
heart
Human
—
—
DAA859
Responsiveness of cholinergic receptors is decreased
Physiological
ileum
Human
—
—
DAA861
Resting and squeeze pressures in anal canal decrease
Physiological
anus
Human
—
—
DAA2594
Resting metabolic rate decreases with ageing
Physiological
whole body
Human
—
—
DAA213
reticulon 1
Molecular
brain
Human
RTN1
8.0% Decrease Gene Expression Level
DAA214
reticulon 4
Molecular
brain
Human
RTN4
8.0% Decrease Gene Expression Level
DAA201
retinoblastoma binding protein 5
Molecular
brain
Human
RBBP5
9.0% Decrease Gene Expression Level
DAA198
retinoic acid receptor responder (tazarotene induced) 2
Molecular
brain
Human
RARRES2
9.0% Increase Gene Expression Level
DAA425
retinoid X receptor, gamma
Molecular
skeletal muscle
Human
RXRG
6.0% Decrease Gene Expression Level
DAA1516
retinol binding protein 1, cellular
Molecular
liver
Mouse
Rbp1
33.0% Increase Gene Expression Level
DAA202
retinol binding protein 4, plasma
Molecular
brain
Human
RBP4
13.0% Decrease Gene Expression Level
DAA276
Rh family, C glycoprotein
Molecular
kidney
Human
RHCG
16.0% Decrease Gene Expression Level
DAA210
Rho family GTPase 1
Molecular
brain
Human
RND1
10.0% Decrease Gene Expression Level
DAA1543
Rho GDP dissociation inhibitor (GDI) alpha
Molecular
liver
Mouse
Arhgdia
9.0% Increase Gene Expression Level
DAA1614
Rho GTPase activating protein 18
Molecular
lung
Mouse
Arhgap18
5.0% Increase Gene Expression Level
DAA1692
Rho GTPase activating protein 26
Molecular
lung
Mouse
Arhgap26
2.0% Increase Gene Expression Level
DAA1087
Rhomboid Domain Containing 1
Molecular
pons
Human
RHBDD1
Increase DNA Methylation
DAA1086
Rhomboid Domain Containing 1
Molecular
frontal lobe
Human
RHBDD1
Increase DNA Methylation
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA1882 | replication factor C (activator 1) 5 | Molecular | skeletal muscle | Mouse | Rfc5 | 13.0% Decrease Gene Expression Level | |
DAA204 | replication factor C (activator 1) 5, 36.5kDa | Molecular | brain | Human | RFC5 | 7.0% Decrease Gene Expression Level | |
DAA811 | Respiratory drive decreases | Physiological | respiratory system | Human | — | — | |
DAA810 | Respiratory muscle strength declines | Physiological | respiratory system, muscle | Human | — | — | |
DAA810 | Respiratory muscle strength declines | Physiological | respiratory system, muscle | Human | — | — | |
DAA812 | Responses to hypoxemia and hypercapnia are decreased | Physiological | respiratory system | Human | — | — | |
DAA897 | Response to antidiuretic hormone decreased | Physiological | renal tubule | Human | — | — | |
DAA708 | Response to beta-adrenergic stimulation decreased | Physiological | heart | Human | — | — | |
DAA859 | Responsiveness of cholinergic receptors is decreased | Physiological | ileum | Human | — | — | |
DAA861 | Resting and squeeze pressures in anal canal decrease | Physiological | anus | Human | — | — | |
DAA2594 | Resting metabolic rate decreases with ageing | Physiological | whole body | Human | — | — | |
DAA213 | reticulon 1 | Molecular | brain | Human | RTN1 | 8.0% Decrease Gene Expression Level | |
DAA214 | reticulon 4 | Molecular | brain | Human | RTN4 | 8.0% Decrease Gene Expression Level | |
DAA201 | retinoblastoma binding protein 5 | Molecular | brain | Human | RBBP5 | 9.0% Decrease Gene Expression Level | |
DAA198 | retinoic acid receptor responder (tazarotene induced) 2 | Molecular | brain | Human | RARRES2 | 9.0% Increase Gene Expression Level | |
DAA425 | retinoid X receptor, gamma | Molecular | skeletal muscle | Human | RXRG | 6.0% Decrease Gene Expression Level | |
DAA1516 | retinol binding protein 1, cellular | Molecular | liver | Mouse | Rbp1 | 33.0% Increase Gene Expression Level | |
DAA202 | retinol binding protein 4, plasma | Molecular | brain | Human | RBP4 | 13.0% Decrease Gene Expression Level | |
DAA276 | Rh family, C glycoprotein | Molecular | kidney | Human | RHCG | 16.0% Decrease Gene Expression Level | |
DAA210 | Rho family GTPase 1 | Molecular | brain | Human | RND1 | 10.0% Decrease Gene Expression Level | |
DAA1543 | Rho GDP dissociation inhibitor (GDI) alpha | Molecular | liver | Mouse | Arhgdia | 9.0% Increase Gene Expression Level | |
DAA1614 | Rho GTPase activating protein 18 | Molecular | lung | Mouse | Arhgap18 | 5.0% Increase Gene Expression Level | |
DAA1692 | Rho GTPase activating protein 26 | Molecular | lung | Mouse | Arhgap26 | 2.0% Increase Gene Expression Level | |
DAA1087 | Rhomboid Domain Containing 1 | Molecular | pons | Human | RHBDD1 | Increase DNA Methylation | |
DAA1086 | Rhomboid Domain Containing 1 | Molecular | frontal lobe | Human | RHBDD1 | Increase DNA Methylation |